The aim is to evaluate the biodistribution and biosafety of a new nanoplatform targeting macrophages for rheumatoid arthritis treatment.
Conducted evaluations of biodistribution and biosafety.
Focused on imaging-guided delivery of nanotheranostics.
The nanoplatform showed excellent biodistribution throughout the target tissues.
Strong biosafety profile supports potential use in clinical applications.
Resumen
evaluations demonstrated the excellent biodistribution and biosafety profile of this nanoplatform, reinforcing its strong potential for clinical translation.